Comparison of the efficacy between Pra-Sa-Prao-Hyai powder and Loratadine in Allergic Rhinitis patients.
Phase 1
Completed
- Conditions
- Allergic rhinitisherb,Allergic rhinitis,Prasasaprohyai
- Registration Number
- TCTR20201003003
- Lead Sponsor
- Faculty of Medicine, Thammasat univercity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
age in range 20 - 80 years old, diagnosed with moderate disease symptoms of allergic rhinitis (classified followed ARIA criteria), ceased using antihistamine at least 7 days before participating.
Exclusion Criteria
The patients who used nasal spray, had nasal polyp, were pregnant or lactating, had nasal septal perforations or had sinus surgery, patients with serious medical conditions such as congestive heart disease, liver and renal dysfunction, uncontrolled hypertension, severe asthma, tuberculosis, HIV were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method aboratory test Week0, 3, 6 Liver function test, renal function test, CBC, FBS, Cholesterol,Assessment Week0, 3, 6 VAS score,Minimal crossection area, Week0, 3, 6 MCA value
- Secondary Outcome Measures
Name Time Method Side effect Week0, 3,6,8 Record